Numerous clinical studies have established that angiotensin II receptor blockers are effective as antihypertensive therapy and are well tolerated. Studies demonstrate that adding an angiotensin II ...

In an NIH-sponsored trial, researchers examined whether an α-adrenergic-receptor blocker — a drug commonly ... 6 weeks (median symptom duration, 1.2 years) and scores ≥12 on a 43-point ...

domains of the two receptors are brought into close proximity, initiating an NF-κB signal transduction cascade. Due to the potent inflammatory response invoked by IL-1 family cytokines, several ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Inflammatory parameters were defined as hs-C-reactive protein (hs-CRP), PAI-1, MMP9, IL6, LCN2, LCN2-MMP9 ... Subjects using glucocorticoids, contraceptives, or some interfering drugs, such ...

Also called alpha-adrenergic blocking agents or alpha-1 blockers, these blood pressure ... Some drugs can block both alpha- and beta-receptors. That may help decrease your blood pressure more ...

Authors say large, multisite study should provide reassurance for short-term risk. HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for ...

Our studies of the relationship between prolactin structure and function have resulted in the development of pure prolactin-receptor antagonists ... actions (Box 1) has yet to be accurately ...

and alpha 1 adrenergic receptor antagonists 8 have been studied with some success. Potassium channel openers, prostaglandins, cyclooxygenase inhibitors, and drugs that reduce afferent activity are ...

Unlike some ad blockers, it doesn’t have other complementary features. Downloading this tool requires a $1.99 one-time fee, which is very affordable. AdGuard is another superb ad blocker you can ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders. HealthDay News — For people with diabetes, the use of glucagon ...